Free Trial

Chemed (CHE) Competitors

Chemed logo
$544.75 -5.35 (-0.97%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$545.90 +1.15 (+0.21%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHE vs. LH, DGX, DVA, CRVL, AMED, MD, AMN, CCRN, OPCH, and BTSG

Should you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Option Care Health (OPCH), and BrightSpring Health Services (BTSG).

Chemed vs.

Laboratory Co. of America (NYSE:LH) and Chemed (NYSE:CHE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Laboratory Co. of America has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$13.01B1.61$746M$8.8228.33
Chemed$2.26B3.62$272.51M$19.7927.53

Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America5.73% 15.29% 7.01%
Chemed 12.69%27.86%19.12%

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Laboratory Co. of America received 290 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 63.99% of users gave Laboratory Co. of America an outperform vote while only 63.48% of users gave Chemed an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
622
63.99%
Underperform Votes
350
36.01%
ChemedOutperform Votes
332
63.48%
Underperform Votes
191
36.52%

Laboratory Co. of America has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Chemed has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500.

In the previous week, Laboratory Co. of America had 5 more articles in the media than Chemed. MarketBeat recorded 15 mentions for Laboratory Co. of America and 10 mentions for Chemed. Laboratory Co. of America's average media sentiment score of 1.19 beat Chemed's score of 1.15 indicating that Laboratory Co. of America is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
12 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.4%. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Chemed pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years.

Laboratory Co. of America currently has a consensus price target of $265.31, suggesting a potential upside of 6.18%. Chemed has a consensus price target of $641.50, suggesting a potential upside of 17.76%. Given Chemed's stronger consensus rating and higher possible upside, analysts plainly believe Chemed is more favorable than Laboratory Co. of America.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.88
Chemed
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Laboratory Co. of America beats Chemed on 12 of the 22 factors compared between the two stocks.

Get Chemed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHE vs. The Competition

MetricChemedHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$8.20B$3.06B$5.77B$20.07B
Dividend Yield0.36%0.36%4.78%3.65%
P/E Ratio27.5328.8226.4634.90
Price / Sales3.621.20455.0215.64
Price / Cash22.6217.8044.0420.85
Price / Book7.413.377.634.92
Net Income$272.51M-$57.02M$3.18B$1.02B
7 Day Performance-1.51%-4.39%-1.91%-1.05%
1 Month Performance-1.54%-5.89%-0.19%-1.09%
1 Year Performance-8.71%24.64%16.70%13.70%

Chemed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHE
Chemed
4.7177 of 5 stars
$544.75
-1.0%
$641.50
+17.8%
-7.4%$8.20B$2.26B27.5315,087Upcoming Earnings
Dividend Announcement
LH
Laboratory Co. of America
4.7642 of 5 stars
$246.74
+0.8%
$265.31
+7.5%
+14.7%$20.64B$13.01B27.9867,000Positive News
DGX
Quest Diagnostics
4.9202 of 5 stars
$168.97
+0.1%
$177.69
+5.2%
+36.1%$18.86B$9.87B21.9748,000Insider Trade
Analyst Revision
Positive News
DVA
DaVita
4.283 of 5 stars
$156.95
-11.4%
$161.80
+3.1%
+17.7%$12.87B$12.14B16.9370,000Analyst Forecast
High Trading Volume
CRVL
CorVel
1.2253 of 5 stars
$117.33
-1.5%
N/A+24.8%$5.98B$795.31M69.024,870Analyst Downgrade
Insider Trade
AMED
Amedisys
3.5082 of 5 stars
$92.60
-0.2%
$100.75
+8.8%
-3.4%$3.03B$2.24B36.7519,000News Coverage
MD
Pediatrix Medical Group
1.5709 of 5 stars
$14.06
-2.8%
$16.25
+15.6%
+79.9%$1.21B$1.99B-4.605,170Earnings Report
Analyst Forecast
News Coverage
AMN
AMN Healthcare Services
4.3282 of 5 stars
$23.40
+0.1%
$44.50
+90.2%
-53.5%$890.69M$3.79B16.953,585Earnings Report
Analyst Forecast
News Coverage
Gap Up
High Trading Volume
CCRN
Cross Country Healthcare
3.4332 of 5 stars
$18.15
-0.3%
$18.54
+2.1%
+6.3%$595.68M$2.02B-362.9310,831Positive News
OPCH
Option Care Health
4.0267 of 5 stars
$31.46
-1.1%
$32.25
+2.5%
-4.1%$5.35B$4.30B26.447,802Positive News
BTSG
BrightSpring Health Services
1.8058 of 5 stars
$22.05
-0.1%
$19.42
-11.9%
+93.7%$3.84B$10.59B-84.8135,000

Related Companies and Tools


This page (NYSE:CHE) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners